Countdown Clock Clicks Closer to " End of July "
Extract from this Release:
Telix is progressing multiple marketing authorisation applications across its precision medicine (diagnostic) portfolio, including:
• New Drug Application (NDA) submission for new prostate cancer imaging agent TLX007-CDx (PSMA-PET imaging5 ):
Telix submitted a NDA to the FDA for a new PSMA targeting prostate cancer imaging agent designed to expand the availability, distribution and
scheduling flexibility for PSMA-PET imaging6
. The FDA is expected to confirm by the end of July 2024 whether the submission is accepted for review.
Confirmation of the PDUFA7 goal date (review timeframe) is expected in early August 2024, in line with FDA procedure.
Countdown Clock Clicks Closer to " End of July "Extract from...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.69 |
Change
-0.320(1.78%) |
Mkt cap ! $5.919B | |||
| Open | High | Low | Value | Volume |
| $18.01 | $18.11 | $17.53 | $23.39M | 1.318M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4025 | $17.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.71 | 1255 | 2 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| TLX (ASX) Chart |